NRIX (STOCKS)
Nurix Therapeutics, Inc. Common stock
$25.310000
+1.640000 (+6.93%)
Prev close: $23.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arthur T. Sands
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,722.51M
- Employees
- 286
- P/E (TTM)
- 10.23
- P/B (TTM)
- 2.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
12
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2026 (Q3)
|
$4.73 | $-0.61 | +5.3429 | +871.74% |
|
Jun 2026 (Q2)
|
$-0.81 | $-0.73 | -0.0788 | -10.78% |
|
Mar 2026 (Q1)
|
$-0.79 | $-0.77 | -0.0206 | -2.68% |
|
Dec 2025 (Q4)
|
$-0.82 | $-0.89 | +0.0680 | +7.66% |